Laurel Wealth Advisors LLC Cuts Position in Amgen Inc. $AMGN

Laurel Wealth Advisors LLC significantly reduced its stake in Amgen Inc. by 99.6% during the third quarter, decreasing its holdings to 23,691 shares. Despite this large sale, other institutional investors like Vanguard Group Inc., Charles Schwab Investment Management Inc., and Panagora Asset Management Inc. increased their positions in the medical research company. Amgen recently reported strong earnings, beating analyst estimates, and increased its quarterly dividend, signaling positive financial performance and investor returns.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin